Cite

HARVARD Citation

    Earl, H. et al. (2021). Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Clinical oncology. 33 (1), pp. 15-19. [Online]. 
  
Back to record